The UK says it will be the first to conduct stimulant trials on the COVID-19 vaccine in humans.
This is different from vaccine studies. People will intentionally become inflamed with the virus, speeding up the search process.
Pending approval, the procedure will begin in January at a London hospital and approximately 90 healthy young adults will be needed between the ages of 18 and 30.
The 1 Day Sooner organization has recruited 3000 Britons from all over the world.
“If the vaccine works, it’s ideal for other people not to be inflamed and, if other people do, they will be rigorously monitored and treated, but because it’s other young, healthy people who participate in the trial, I think researchers feel comfortable doing so, because the death threat is comparable to anything like kidney donation for other healthy young people. ” Abie Rohrig said 1 day earlier.
Before researchers check the vaccine, they will conduct a characterization study, where volunteers become inflamed when they receive a vaccine to determine the correct amount of virus to administer the trial.
Due to the risk, 1 Day Sooner advocates that the procedure be made public.
Effects can come in May. Although this is most likely after the authorization of other COVID-19 vaccines, it is still because we want billions of doses and the unique knowledge provided through human provocation trials.
“Researchers can perceive how the virus works in the human body. Possibly they would come with biological markers of immunity. In fact, much of our perception of other types of coronavirus comes from challenge studies conducted in the 1960s in Britain,” Rohrig said. Said.
Human Challenge volunteers are paid and supervised for at least a year.